XARELTO RIVAROXABAN
Live / Registered — Registered and renewed (as of 28 Jul 2022)
What this means for you
Registered since 21 Feb 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Feb 2022).
Record
- Serial number
- 77752447
- Registration number
- 4102740
- Mark type
- Design + words
- Filed
- 04 Jun 2009
- Published for opposition
- 27 Oct 2009
- Registered
- 21 Feb 2012
- Next maintenance due
- 21 Feb 2022
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of cardiovascular diseases, thrombosis, stroke and pulmonary embolism
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, 51373 Leverkusen, DE
- Bayer Aktiengesellschaft, 51373 Leverkusen, DE
Prior registrations
Prosecution history
- 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Jul 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 28 Jul 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Jul 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jan 2022 — TEAS SECTION 8 & 9 RECEIVED
- 21 Feb 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Feb 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Feb 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Feb 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Feb 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Feb 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Feb 2018 — TEAS SECTION 8 & 15 RECEIVED